Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06608979 · ClinicalTrials.gov registry record · NA

Trauma Screening/Referral and Interpersonal Violence Prevention for Women with Substance Use Disorders

A NA study of Post Traumatic Stress Disorder and Opioid Use Disorder, sponsored by Clemson University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
2
Study locations

NCT06608979: Recruiting NA study of Post Traumatic Stress Disorder and Opioid Use Disorder, sponsored by Clemson University.

NCT06608979 is a NA study of Post Traumatic Stress Disorder and Opioid Use Disorder that is actively recruiting participants, run by Clemson University. The registered enrollment target is 60 participants, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06608979, a NA study of Post Traumatic Stress Disorder and Opioid Use Disorder, is actively recruiting participants, sponsored by Clemson University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this project is to implement a pilot study to investigate the feasibility and preliminary efficacy of a peer support specialist delivered violence prevention program for women in substance use treatment. The program entails a posttraumatic stress disorder (PTSD) screening, resource referral, and two session interpersonal violence prevention protocol for 60 participants. In this single arm trial, women are recruited from three substance use treatment facilities. Participants complete baseline, post-intervention, one-month, and three-month follow-up assessments. Self-report surveys assess trauma exposure, knowledge and behaviors related to interpersonal violence, and intervention engagement.

Interventions

  • BEHAVIORAL Screening/Referral and Prevention

Study Locations (2)

South Carolina

  • Addiction Medicine Clinic, Prisma Health Upstate - Greenville
  • The Phoenix Center - Greenville

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-06-11
Est. Completion 2025-03
Phase NA
Clemson University

13 total trials

What NCT06608979 shows while recruiting

NCT06608979 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (91% lower).

The record links to 6 conditions, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 1 intervention - of which Screening/Referral and Prevention is the first listed.

NCT06608979 reports a single indexed study location in South Carolina.

Frequently Asked Questions

What is clinical trial NCT06608979 about?

NCT06608979 is a clinical study titled "Trauma Screening/Referral and Interpersonal Violence Prevention for Women with Substance Use Disorders". The purpose of this project is to implement a pilot study to investigate the feasibility and preliminary efficacy of a peer support specialist delivered violence prevention program for women in substance use treatment. The program entails a posttraumatic stress disorder (PTSD) screening, resource re...

What is the current status of trial NCT06608979?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-06-11. Estimated completion is 2025-03.

What conditions does trial NCT06608979 study?

This clinical trial studies the following conditions: Post Traumatic Stress Disorder, Opioid Use Disorder, Substance Use Disorders, Violence, Domestic, Violence, Sexual.

What interventions are being tested in trial NCT06608979?

The interventions under investigation include: Screening/Referral and Prevention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06608979?

This trial is sponsored by Clemson University, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06608979 being conducted?

This trial has 2 study locations across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post Traumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06608979's enrollment target sits among peer trials

60 160th of 262 higher than 96 of 262 other Post Traumatic Stress Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06608979, the US trial registry maintained by the National Library of Medicine. NCT06608979 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.